5F9-23807-90208
4 vaccinations
2 coded responses
45 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-13
-
2021-02-18
Dose 2 — Pfizer-BioNTech
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-05-20
- 2021-08-21
-
2021-10-06
Dose 3 — Pfizer-BioNTech
- 2021-10-06
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Cough — Feeling: Fair · Site: PainFree text: Coughprobably unrelated and from my child's coldMedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-10
- 2021-10-12
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2022-01-05
- 2022-04-06
-
2022-09-08
Dose 4 — Pfizer-BioNTech
- 2022-09-19
- 2022-09-22
- 2022-09-29
- 2022-10-08
- 2022-10-13
- 2022-10-22
- 2022-12-08
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: COVID-19, Influenza, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-09
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-09 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Coughprobably unrelated and from my child's cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release